# Clivia Capital

> Clivia Capital is a VC fund in Suzhou backing Electronics, Health Care and Manufacturing. See 8 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Suzhou, China
- Total investments: 8
- Last investment: Jul 2024
- Lead investor: 13%
- Last updated: Aug 2026
- Website: http://www.szclivia.com/

Clivia Capital is a private equity firm that invests in a full range of private equity opportunities.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Electronics | 2 | 25% |
| Health Care | 2 | 25% |
| Manufacturing | 2 | 25% |
| Semiconductor | 2 | 25% |
| Medical | 1 | 13% |

16 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Funding Round | 3 | 38% |
| Seed | 2 | 25% |
| Series A | 1 | 13% |
| Series B | 1 | 13% |
| Venture - Series Unknown | 1 | 13% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Avant Semi | Avant Semi is a high tech enterprise engaged in semiconductor front-end measurement and testing equipment industry. |  | Venture - Series Unknown | Jul 25, 2024 |  |
| Shanghai Lianfeng | Shanghai Lianfeng is a high-tech enterprise that manufactures gas separation and purification equipment in the direction of energy conservation and environmental protection. |  | Venture - Series Unknown | Jan 03, 2024 |  |
| ecMAX | ecMAX is an e-commerce operation service and digitalized retailing solution provider. | $14.1M | Venture - Series Unknown | Jan 03, 2024 |  |
| Yixi Biotech | Yixi Biotech is a provider of solutions for the intestinal microbiology sector, focusing on providing solutions for the intestinal microbiology sector. It mainly distributes three research and development pipelines for diabetes, depression and tumor reconstitution after tumor chemotherapy, focusing on intestinal microbes and human body. Research onhealth mechanisms, research on intestinal microecology and intestinal immune microenvironment interaction mechanisms and disease intervention strategies, and research and development of alternative treatment protocols, synthetic biological strains and drugs for the treatment of intestinal microbial diseases. | $14.2M | Seed | Aug 22, 2023 |  |
| Keyang Semiconductor | Keyang is mainly engaged in the design, R&D, manufacture, packaging, and testing of semiconductor TSV package integrated circuit products. | $72.7M | Venture - Series Unknown | Apr 03, 2023 |  |
| Neomodulus | Nuoyimeier is a developer of implantable consumables. |  | Series B | Mar 07, 2023 |  |
| Hyseim | Hyseim addresses the new computing needs caused by the integration of smart car electronics and AIOT industrial scenarios. | $14.5M | Seed | Dec 30, 2022 |  |
| Polly Polymer | Polly Polymer is a manufacturer of 3D printing terminals. They are engaged in the research and development of dental and medical polymer materials and 3D printing for sports equipment, medical devices, consumer electronics, automobiles, and other industries, enabling clients to shorten the research and development cycle and reduce costs. PollyPolymer, with its superior materials and large-scale 3D printing production, has become a catalyst for corporate digital intelligent manufacturing transformation, upgrading, and innovation. | $30.9M | Series A | Sep 21, 2021 |  |

8 of 8 investments shown.

## Co-investors
- [CDH Investments](https://shizune.co/investors/profile/cdh-investments) — VC Fund, 2 deals together
- [Sunic Capital](https://shizune.co/investors/profile/sunic-capital) — VC Fund, 2 deals together
- 10Fund — VC Fund, 1 deal together
- Caitong Securities — VC Fund, 1 deal together
- [China Fortune-Tech Capital](https://shizune.co/investors/profile/china-fortune-tech-capital) — VC Fund, 1 deal together
- [China Merchants Venture Capital](https://shizune.co/investors/profile/china-merchants-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

## FAQ

### What does Clivia Capital invest in?

Clivia Capital invests primarily in Electronics, Health Care and Manufacturing startups, most often at Funding Round and Seed stage. Most of the 8 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Clivia Capital last invest?

The most recent investment recorded for Clivia Capital closed in Jul 2024. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co